Skip to main content
. 2020 Jan 8;9(1):149. doi: 10.3390/cells9010149

Figure 3.

Figure 3

Kaplan-Meier analysis of overall survival and disease-free survival in 108 patients with advanced ovarian cancers stratified by stronger fibronectin expression (score 2 & 3) versus weak fibronectin expression (score 1) in the tumor stroma.